Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Multi-Morbidity and Polypharmacy in Older People: Challenges and Opportunities for Clinical Practice

Version 1 : Received: 31 August 2020 / Approved: 2 September 2020 / Online: 2 September 2020 (06:04:17 CEST)

How to cite: Aggarwal, P.; Woolford, S.; Patel, H. Multi-Morbidity and Polypharmacy in Older People: Challenges and Opportunities for Clinical Practice. Preprints 2020, 2020090030 (doi: 10.20944/preprints202009.0030.v1). Aggarwal, P.; Woolford, S.; Patel, H. Multi-Morbidity and Polypharmacy in Older People: Challenges and Opportunities for Clinical Practice. Preprints 2020, 2020090030 (doi: 10.20944/preprints202009.0030.v1).

Abstract

Multi-morbidity and polypharmacy are common in older people and pose a challenge for health and social care systems especially in context of global population ageing. They are complex and interrelated concepts in the care of older people that require early detection and patient centred decision making that are underpinned by the principles of multidisciplinary led comprehensive geriatric assessment (CGA). Personalised care plans need to remain responsive and adaptable to the needs of a patient, enabling an individual to maintain their independence.

Subject Areas

multi-morbidity; CGA; frailty; polypharmacy; deprescribing

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.